Give Feedback
Showing 227 results
  • June 30, 2025
    In today’s dynamic healthcare landscape, Patient and Member Engagement (PME) has become a strategic imperative for healthcare enterprises and service and platform providers. Historically overlooked and limited to administrative touchpoints, PME has evolved into a mission-critical function that impacts patient/member satisfaction and business outcomes, such as retention, medication adherence, care outcomes, and cost improvements. Rising expectations, omnichannel demand, regulatory pressures, and advanced technology have accelerated the transition toward seamless, intelligent, and personalized engagement across the care journey.  In this report, we analyze the PME’s evolving role in healthcare and its significance in driving better outcomes. The report assesses key adoption trends, identifies technology and organizational accelerators, and highlights the barriers that limit PME’s scaling across the industry. Focusing on real-world enterprise priorities, the report outlines how healthcare organizations are using gen AI, predictive analytics, and agentic AI to enable self-service, deliver personalized communication, and proactively retain members and patients.  Additionally, the report examines the emergence of Systems of Execution (SoE) and their potential to unify data, drive AI-led engagement, and convert insights into real-time execution across touchpoints. It also provides sourcing guidance and strategic recommendations for payers and providers, emphasizing the need for a PME lead to drive enterprise alignment and measure experience success. 
  • June 30, 2025
    Retail enterprises are struggling with rapidly shifting consumer expectations, technology-led disruptions, and persistent economic pressures. As they seek to balance growth with profitability, many are increasing investments in digital technologies and seeking partners with deep industry expertise and engineering-led capabilities. Retailers are prioritizing unified commerce, real-time analytics, and experience-led transformation, where providers are vital in enabling agility and resilience. In this report, we analyze how 33 leading retail service providers respond to evolving enterprise needs through vertically integrated offerings, IP-led solutions, and ecosystem-based delivery models. The report highlights how providers are helping clients modernize core systems, build data-driven supply chains, and adopt gen AI, cloud, and automation at scale.
  • June 27, 2025
    The Supply Chain Transformation Services for Retail and Consumer Packaged Goods (CPG) – State of the Market 2025 report comprehensively examines how RCPG enterprises are reimagining their supply chains amid digital disruption, shifting consumer expectations, and geopolitical pressures. The study highlights how providers are integrating IT and business process services with AI, analytics, and automation to drive visibility, inventory optimization, and last-mile delivery. Key insights include: Market size and growth trends across geographies, buyer segments, and service areas Shifts toward integrated IT-BP engagements and agile, tech-driven deal models Strategic priorities such as ESG compliance, AI-enabled forecasting, and supply chain as-a-service Changing commercial models, talent strategies, and delivery footprints The report also explores provider investments, partner ecosystems, and implications for both enterprises and providers, offering strategic guidance to build future-ready, resilient supply chains.
  • June 25, 2025
    Life sciences enterprises operate in an increasingly complex engagement landscape due to rising content fatigue, expanding Healthcare Professional (HCP)/patient touchpoints, and growing stakeholder expectations for relevance. Traditional engagement strategies, characterized by fragmented data, siloed operational workflows, and legacy technology systems built for function-level enablement, have led to disjointed engagement and effort duplicity across enterprise teams. Systems of Execution (SoE) address this challenge by acting as an intelligent execution layer that unifies data across commercial, medical affairs, and patient services to activate cross-functional synergies in delivering coordinated stakeholder-centric omnichannel engagement across the enterprise. By leveraging real-time data signals, AI-powered next-best-action recommendations, and automated adaptive engagement workflows, SoE enable enterprises to autonomously deliver personalized and contextually relevant stakeholder interactions with minimal human intervention. This report outlines core SoE capabilities and provides life sciences CXOs with a clear implementation roadmap. It helps life sciences CXOs achieve personalized, enterprise-scale omnichannel execution, designed to surface cross-functional insights and autonomously act on them, to deliver coordinated omnichannel engagement across enterprise functions.
  • June 10, 2025
    Life sciences enterprises are under increasing pressure to accelerate innovation, optimize costs, and embrace emerging technologies like AI. These priorities are reshaping how and where organizations source capabilities, prompting a fresh look at the roles of Global Capability Centers (GCCs) and service providers. GCCs are gaining renewed focus as enterprises invest in internal talent and domain expertise, while service providers continue to play a critical role in delivering flexibility, scale, and specialized capabilities. However, very few conversations bring both sides of the sourcing story to the table. Watch Everest Group’s experts as they explored how life sciences sourcing strategies are evolving in an AI-first world and where enterprises are choosing to build vs. buy capabilities. What questions did the webinar answer? How are life sciences enterprise priorities changing, and what is the impact on the sourcing strategy? What capabilities are companies increasingly looking to bring in-house through GCCs, and which are they turning to service providers to deliver? In an AI-first world, how is the value proposition evolving for both models?
  • June 04, 2025
    Healthcare enterprises are increasingly recognizing the strategic value of Data, Analytics, and AI (DAAI) as data-driven decision-making becomes central to achieving business and clinical outcomes. While DAAI initiatives have traditionally focused on cost containment and operational efficiencies, there is now a clear shift toward enhancing patient experiences and driving improved health outcomes. This evolving focus is prompting organizations to invest in robust data integration capabilities and advanced analytics, with particular emphasis on data privacy, value-based care, and population health management. Although payers have historically led DAAI adoption, providers are rapidly advancing their capabilities. They are essential in shaping enterprise DAAI strategies and roadmaps, modernizing infrastructure, and delivering actionable insights that support high-impact decision-making. As a result, healthcare organizations are realizing measurable improvements in performance, care delivery, and patient engagement. In this report, we assess 32 healthcare DAAI providers featured on the Healthcare Data, Analytics, and AI Services PEAK Matrix® Assessment 2025. The report analyzes the healthcare DAAI services market size, DAAI service themes for healthcare enterprises, and providers’ capabilities and market success. The research will enable enterprises to select the best-fit provider for their sourcing needs. Scope Industry: healthcare Service: healthcare DAAI services Geography: global Contents In this report, we assess: Healthcare DAAI services market trends Each provider’s capabilities and market success Providers’ key strengths and limitations
  • May 08, 2025
    Escalating tariffs and retaliatory measures are fundamentally altering global sourcing strategies and operational cost structures today. This disruption is forcing retail and CPG organizations to reevaluate their technology roadmaps, delay full-suite technology upgrades, and instead focus on modular, high-impact investments tied to sourcing agility, cost visibility, and inventory resilience. This viewpoint offers a practical framework for enterprises to evaluate their readiness across two critical dimensions – tariff resilience and platform readiness – while aligning their transformation priorities effectively. The report also outlines how organizations can realign their transformation roadmaps by identifying core and non-core initiatives. Service providers can reposition themselves by offering modular, intelligence-driven solutions, such as tariff simulation engines and outcome-linked pricing models. Designed for enterprise leaders and provider executives, this viewpoint delivers actionable insights to convert near-term trade turbulence into a strategic inflection point for long-term operational resilience. Scope Industry: retail and CPG Geography: North America Contents In this viewpoint, we: Evaluate the impact of tariffs and regulations on retailers’ and CPG enterprises’ technology and operations spends Assess enterprises’ tariff resilience and technology readiness Provide insights on how providers can focus on specific solutions in the value chain to help enterprises navigate changes in an agile manner Memberships Retail and CPG Sourcing and Vendor Management
  • May 07, 2025
    The life sciences R&D engine is rapidly digitizing, and clinical development software now sits at its center. This report sizes the global clinical trials technology market at nearly US$6.5 billion for 2025 (8-10% CAGR) and dissects its four core segments – Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), Decentralized Clinical Trial (DCT) platforms, and clinical data and analytics suites. This study maps demand surges in oncology, rare disease, neurology, and obesity trials and examines the contrasting pressures of build-versus-buy debates and heightened data privacy scrutiny. Beyond market numbers, the report spotlights whitespaces such as end-to-end interoperability, real-time visualization, and true low/no-code configurability, analyzes segment-specific product trends (AI-driven EDC validation, next-generation CTMS forecasting, patient-centric DCT designs, and unified analytics hubs), and details the investment priorities sponsors and CROs are setting for 2025. A forward-looking section explores generative AI and agentic AI use cases, from autonomous protocol design to real-time safety monitoring, and outlines adoption stages and success prerequisites. These insights equip stakeholders to refine technology roadmaps, close capability gaps, and accelerate drug-development timelines. Scope Industry: life sciences Geography: global Contents In this report, we examine: 2023-25 clinical technology market size, growth, and segment mix Therapeutic area demand and shifting R&D spend Growth drivers and inhibitors Persistent gaps and sponsor-sourcing criteria Product-innovation themes across EDC, CTMS, DCT, and analytics High-potential generative AI and agentic AI applications and adoption stages 2025 investment priorities for sponsors, CROs, and technology providers
  • April 22, 2025
    As US healthcare providers grapple with a turbulent economic and regulatory landscape, new tariffs and evolving policies are reshaping operational and financial realities across the sector. In response, providers are reassessing spending, delaying technology investments, and seeking more cost-effective operations. This report explores how Revenue Cycle Management (RCM) providers can strategically help healthcare organizations navigate this disruption. It highlights key actions such as adopting flexible pricing, enhancing operational agility, and deploying targeted AI to improve efficiency and safeguard revenue. Designed for RCM leaders and healthcare stakeholders, the report offers practical guidance on turning disruption into opportunity by aligning solutions with shifting provider needs. Scope Industry: healthcare Geography: North America Contents This report covers the impact of tariffs and regulations on healthcare providers and outlines strategic and portfolio-specific actions RCM providers can take to mitigate risk, enhance value, and drive growth. Memberships Healthcare Payer and Provider Business Process Revenue Cycle Management Sourcing and Vendor Management
  • April 14, 2025
    Supply chain services are the most significant investment area for Retail and Consumer Packaged Goods (RCPG) firms, driven by the need for agility, resilience, and efficiency. As these firms navigate evolving market dynamics, digital disruptions, and sustainability demands, supply chain transformation has become a strategic priority. To drive meaningful change, providers must offer a holistic approach that integrates IT and business process services with strong advisory capabilities. Advanced analytics, AI-driven insights, and automation are essential in optimizing supply chain operations and improving visibility. Additionally, robust demand forecasting, inventory management, and supplier collaboration capabilities are vital to mitigate risks and ensure seamless execution. Providers must also address industry-specific complexities such as omnichannel fulfillment and last-mile logistics to deliver tailored solutions. Furthermore, ESG-driven supply chain strategies, including circular economy models and carbon footprint reduction, are gaining traction. By combining technology, domain expertise, and strategic guidance, providers can help RCPG firms achieve resilient, customer-centric, and future-ready supply chains. In this compendium, we present comprehensive and fact-based snapshots of the 15 providers featured on the Supply Chain Transformation Services for Retail and CPG PEAK Matrix® Assessment 2025. Each provider’s profile comprehensively outlines its service focus, key intellectual property / solutions, domain investments, and case studies. The assessment is based on Everest Group’s annual RFI process for calendar year 2024, interactions with leading providers, client reference checks, and an ongoing analysis of the RCPG supply chain services market. Scope Industry: RCPG Geography: global Services: supply chain transformation The assessment is based on Everest Group’s annual RFI process for the calendar year 2024, interactions with leading providers, client reference checks, and an ongoing analysis of the RCPG supply chain services market Contents This report features detailed assessments, including profile overviews, key solutions, investment areas, and case studies of 15 providers that focus on supply chain transformation services in the RCPG industry. Memberships Retail and CPG Sourcing and Vendor Management